PB2146: A PHASE 2, OPEN-LABEL STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA-R) IN PREVIOUSLY UNTREATED UNFIT/FRAIL PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOM...

por Westin, J., Burke, J. M., Chapman, A. E., Kilavuz, T., Xu, C., Shmuely, Y., Radford, J.
Publicado 2022